The utility value of ROX index and modified ROX index in determining the efficiency of HFNC in children admitted with respiratory distress

Authors

  • Sravni Kolla Department of Pediatrics, Sri Ramchandra Children’s and Dental Hospital, Guntur, Andhra Pradesh, India
  • Raviteja Meda Department of Pediatrics, Sri Ramchandra Children’s and Dental Hospital, Guntur, Andhra Pradesh, India
  • Lokeswari Balleda Department of Pediatrics, Sri Ramchandra Children’s and Dental Hospital, Guntur, Andhra Pradesh, India
  • Chandrasekhara Reddy Thimmapuram Department of Pediatrics, Sri Ramchandra Children’s and Dental Hospital, Guntur, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20241363

Keywords:

Heart rate, Respiratory rate, High flow nasal cannula, Respiratory distress

Abstract

Background: The ROX index is defined as the ratio of SpO2/FiO2 to respiratory rate. The modified ROX index or ROX-HR index is defined as the ratio of ROX index/heart rate×100. The aim of the study was to determine the utility of the ROX index and the modified ROX index as predictors of initiation and efficiency of HFNC in children admitted with respiratory distress.

Methods: This prospective observational study included 133 children with respiratory distress, who received HFNC. The ROX index, and modified ROX index were measured, and outcomes were recorded.

Results: Total number of study subjects were 133. Statistically significant increase was seen in ROX index and modified ROX index at follow up (p value<0.05). Interpretation of the area under the ROC curve showed that the performance of ROX index and modified ROX index at ‘0’ hour was outstanding. ROX Index and modified ROX Index at a Cut-off of ≤4.7959 and ≤2.5579 respectively at initiation i. e.; at ‘0’ hour predicted HFNC requirement. In prediction of HFNC requirement ROX index at ‘0’ hour had a sensitivity, specificity, positive predictive value, and negative predictive value of 88.24%, 87.84%, 93%, and 80.2% respectively, and modified ROX index had 78.68%, 93.24%, 95.5%, and 70.4% respectively. Low ROX and modified ROX indices at ‘0’ hour predicted prolonged ICU and hospital stays, as well as extended HFNC duration.

Conclusions: Both ROX index, and modified ROX index were good predictors of HFNC requirement.  

 

References

Kwon JW. High-flow nasal cannula oxygen therapy in children: a clinical review. Clin Exp Pediatr. 2020;63(1):3-7.

Ergul AB, Calıskan E, Samsa H, Gokcek I, Kaya A, Zararsiz GE, et al. Using a high-flow nasal cannula provides superior results to OxyMask delivery in moderate to severe bronchiolitis: a randomized controlled study. Eur J Pediatr. 2018;177(8):1299-307.

O'Brien S, Craig S, Babl FE, Borland ML, Oakley E, Dalziel SR, et al. 'Rational use of high-flow therapy in infants with bronchiolitis. What do the latest trials tell us?' A Paediatric Research in Emergency Departments International Collaborative perspective. J Paediatr Child Health. 2019;55(7):746-52.

Nascimento MS, Zólio BA, Vale LAPA, Silva PAL, Souza TS, Gonçalves LHR, et al. ROX index as a predictor of failure of high-flow nasal cannula in infants with bronchiolitis. Sci Rep. 2024;14(1):389.

Valencia CF, Lucero OD, Castro OC, Sanko AA, Olejua PA. Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia. Sci Rep. 2021;11(1):22559.

Chaudhari P, Singh PK, Govindagoudar M, Sharma V, Saxena P, Ahuja A, et al. Utility and timing of the respiratory rate-oxygenation index in the prediction of high-flow oxygen therapy failure in acute hypoxemic respiratory failure of infective etiology: a prospective observational study. Monaldi Arch Chest Dis. 2023;94(1).

Junhai Z, Jing Y, Beibei C, Li L. The value of ROX index in predicting the outcome of high flow nasal cannula: a systematic review and meta-analysis. Respir Res. 2022 Feb 17;23(1):33.

Nascimento MS, Zólio BA, Vale LAPA, Silva PAL, Souza TS, Gonçalves LHR, et al. ROX index as a predictor of failure of high-flow nasal cannula in infants with bronchiolitis. Sci Rep. 2024;14(1):389.

Roca O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care. 2016;35:200-5.

Kim JH, Suh DI, Park JD. S/F and ROX indices in predicting failure of high-flow nasal cannula in children. Pediatr Int. 2022;64(1):e15336.

Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, et al. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019;199(11):1368-76.

Frat JP, Ragot S, Coudroy R, Constantin JM, Girault C, Prat G, et al. Predictors of Intubation in Patients With Acute Hypoxemic Respiratory Failure Treated With a Noninvasive Oxygenation Strategy. Crit Care Med. 2018;46(2):208-15.

Kansal A, Ong WJD, Dhanvijay S, Siosana ATP, Padillo LM, Tan CK, et al. Comparison of ROX index (SpO2/FIO2 ratio/respiratory rate) with a modified dynamic index incorporating PaO2/FIO2 ratio and heart rate to predict high flow nasal cannula outcomes among patients with acute respiratory failure: a single centre retrospective study. BMC Pulm Med. 2022;22(1):350.

Chang CC, Lin YC, Chen TC, Lin JJ, Hsia SH, Chan OW, et al. High-Flow Nasal Cannula Therapy in Children With Acute Respiratory Distress With Hypoxia in A Pediatric Intensive Care UnitA Single Center Experience. Front Pediatr. 2021;9:664180.

Goh KJ, Chai HZ, Ong TH, Sewa DW, Phua GC, Tan QL. Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate. J Intensive Care. 2020;8:41.

Mustafa H, Tariq R, Usman N, Mirza S, Anwarul Haq, Ameer S. Outcome of high-flow nasal cannula (HFNC) therapy in respiratory failure due to lower respiratory tract infections in PICU - a single center experience in Karachi, Pakistan. Professional Med J. 2024;31(05):782-8.

Karim HMR, Bharadwaj A, Mujahid OM, Borthakur MP, Panda CK, Kalbande JV. The Relationship of Respiratory Rate-Oxygenation (ROX) and Modified ROX Index With High-Flow Nasal Cannula Oxygen Therapy in COVID-19 Patients: An Observational Pilot Study. Cureus. 2022;14(12):e32900.

Li Z, Chen C, Tan Z, Yao Y, Xing S, Li Y, et al. Prediction of high-flow nasal cannula outcomes at the early phase using the modified respiratory rate oxygenation index. BMC Pulm Med. 2022;22(1):227.

Yildizdas D, Yontem A, Iplik G, Horoz OO, Ekinci F. Predicting nasal high-flow therapy failure by pediatric respiratory rate-oxygenation index and pediatric respiratory rate-oxygenation index variation in children. Eur J Pediatr. 2021;180(4):1099-106.

Yuniar I, Pudjiadi AH, Dewi R, Prawira Y, Puspaningtyas NW, Tartila T, et al. Respiratory Rate Oxygenation (ROX) index as predictor of high flow nasal cannula in pediatric patients in pediatric intensive care unit. BMC Pulm Med. 2024;24(1):216.

Downloads

Published

2024-05-27

Issue

Section

Original Research Articles